SCHEMBL5330001

SCHEMBL5330001

CCOC(=O)CNC(CCC(=O)O)C(=O)OCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
KMT2A Q03164 2/20 0.50
POLB P06746 1/20 0.50
GAA P10253 2/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
FOLH1 Q04609 2/20 0.38
RIMKLA Q8IXN7 1/20 0.38
NAALAD2 Q9Y3Q0 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21271459 0.90 L3MBTL1 (0.65) L3MBTL1KMT2APOLBGAAMGAM
SCHEMBL21271462 0.90 L3MBTL1 (0.65) L3MBTL1KMT2APOLBGAAMGAM
SCHEMBL21271460 0.90 L3MBTL1 (0.65) L3MBTL1KMT2APOLBGAAMGAM
SCHEMBL5409583 0.81 L3MBTL1 (0.51) L3MBTL1KMT2APOLBGAAMGAM
SCHEMBL29076127 0.81 GABRP (0.42) L3MBTL1KMT2APOLBGAAMGAM
SCHEMBL29076125 0.81 GABRP (0.42) L3MBTL1KMT2APOLBGAAMGAM
SCHEMBL11186485 0.80 GAA (0.48) L3MBTL1KMT2APOLBGAAMGAM
SCHEMBL22316082 0.79 L3MBTL1 (0.50) L3MBTL1KMT2APOLBFOLH1RIMKLA
SCHEMBL28539939 0.79 L3MBTL1 (0.50) L3MBTL1KMT2APOLBFOLH1RIMKLA
SCHEMBL4986346 0.79 L3MBTL1 (0.44) L3MBTL1KMT2APOLBGAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7175767-B2 Preparation of a metal chelating separation medium GE HEALTHCARE BIO-SCIENCES AB (SE) 2007-02-13 US disclosed
US-20060199950-A1 Preparation of a metal chelating separation medium GE HEALTHCARE BIO-SCIENCES AB (SE) 2006-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199950-A1 Preparation of a metal chelating separation medium CA1, CA3, CA12 L3MBTL1 3959/4885KMT2A 468/4885POLB 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.